In a striking example of nature's ingenuity, a collaborative research team has revealed that a bioluminescent fish glows not ...
What if chronic diseases, which are difficult to treat with medicine alone, could be managed with electricity? As ...
Beverly Hills spine surgeon and principal investigator will present pooled clinical outcomes following recent FDA ...
A 2026 informational overview of BackRestore's Regenesis Tri-Therapy System for chronic lower back pain, herniated disc support, and pinched nerve relief — how the company describes its home spinal ...
After receiving a life-changing spina bifida diagnosis at 20 weeks, Maddi Vance chose a groundbreaking fetal surgery to give ...
MDA’s research funding for Dr. Adrian Krainer’s research led to the groundbreaking discovery of SPINRAZA®. FDA Approves High ...
Keep sending in your questions to: hellodoctor@timesofindia.comWelcome to another edition of Hello, Doctor — the TOI+ series ...
Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS™ surgical system for cranial and ear, nose, and ...
Chronic pain affects 1 in 5 adults in developed countries. Most of them never find the source. The source is often spinal ...
KUTV — For patients suffering from chronic, severe back pain that hasn’t responded to traditional treatments, a spinal cord stimulator (SCS) may offer new hope. Dr. Jeff Pence, Interventional Spine ...
CONTEXT: Hemangiopericytoma is an uncommon mesenchymal neoplasm that rarely affects the spinal canal. Primary malignant hemangiopericytoma of the spinal column is extremely rare. CASE REPORT: We ...